ADC Therapeutics SA Dividends
The next dividend date for ADC Therapeutics SA has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for ADC Therapeutics SA (ADCT)
More About ADC Therapeutics SA
ADC Therapeutics SA provides antibody drug conjugate (ADC) technology platform to transform the treatment paradigm for patients with hematologic malignancies and solid tumors. Its flagship product includes ZYNLONTA, a CD19-directed ADC, received accelerated approval from the U.S. Food and Drug Administration, conditional approval from the European Commission, and conditional approval from the China National Medical Products Administration for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after two or more lines of systemic therapy. The company is also seeking to continue expanding ZYNLONTA into international markets and into earlier lines of DLBCL and indolent lymphomas, including follicular lymphoma (FL) and marginal zone lymphoma (MZL) as a single agent and in combination through its LOTIS-5 confirmatory Phase 3 clinical trial and LOTIS-7 Phase 1b clinical trial, as well as through investigator-initiated trials (IITs). In addition, it is investigating a CD-22 targeted compound' and ADCT-602 that is in a Phase 1/2 IIT in refractory B-cell acute lymphoblastic leukemia. Further, the company's pre-clinical stage pipeline includes a portfolio of next generation investigational ADCs targeting Claudin-6, NaPi2b, PSMA, NaPi2b, and ASCT2. ADC Therapeutics SA was incorporated in 2011 and is headquartered in Epalinges, Switzerland.
Owning ADC Therapeutics SA Stock on the Dividend Date
If you own ADC Therapeutics SA stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of ADC Therapeutics SA stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of ADC Therapeutics SA stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying ADC Therapeutics SA stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the ADC Therapeutics SA dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Learning More ADC Therapeutics SA Dividends
You can contact us any time if you would like to ask questions about ADC Therapeutics SA dividends or anything else related to the stock market.